Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Emerald BioStructures, UCB Extend Collaboration

October 27, 2011 12:16 pm | News | Comments

Emerald BioStructures announced a three-year extension of its ongoing collaboration with UCB.

TOPICS:

Almac Invests $1.4 Million in Laboratory

October 27, 2011 12:12 pm | News | Comments

Almac has established a mass spectrometry laboratory in their European Headquarters, Craigavon, United Kingdom.

TOPICS:

Digital Thermometer

October 27, 2011 8:15 am | Product Releases | Comments

Control Company’s Traceable digital hygrometer/thermometer/dew point instrument provides a response time of under 10 seconds with a resolution of 0.01% RH, 0.01°F/°C, and 0.01° dew point °F/°C.

TOPICS:
Advertisement

Water Purification Unit

October 27, 2011 8:10 am | Product Releases | Comments

The arium pro from Sartorius Stedim Biotech provides ultrapure water for analytical applications like atomic absorption, ion exchange chromatography and inductively coupled plasma mass spectrometry.

TOPICS:

Boehringer Buys Hamilton System for Research Center

October 27, 2011 7:53 am | News | Comments

Hamilton Storage Technologies and Robotics have delivered and successfully installed an integrated compound management system at Boehringer Ingelheim's Research and Development Centre.

TOPICS:

Activartis in Phase 2 Trial of Cancer Therapy

October 27, 2011 7:45 am | News | Comments

Activartis GmbH is developing a cancer immunotherapy concept which is currently in Phase 2 clinical trials. The Activartis platform focuses on dendritic cells, the key regulatory elements of the immune system.

TOPICS:

Victoza Boosts Novo Nordisk Profits

October 27, 2011 7:39 am | News | Comments

Danish pharmaceutical company Novo Nordisk A/S says its net profit grew by 17% in the third quarter, chiefly spurred by strong sales of its new diabetes drugs.

TOPICS:

EU Expands Prevnar Approval

October 27, 2011 7:35 am | News | Comments

Pfizer Inc.'s blockbuster vaccine against dangerous bacterial infections has been approved in Europe for use in adults age 50 and older, the drugmaker announced.

TOPICS:
Advertisement

AstraZeneca Profits Drop 2%

October 27, 2011 7:32 am | News | Comments

Drug maker AstraZeneca says underlying profit was down 2% in the third quarter but net profit more than doubled because of the sale of a subsidiary.

TOPICS:

Bayer Earnings More Than Double

October 27, 2011 7:30 am | News | Comments

Bayer AG says its earnings more than doubled in the third quarter compared with a year-earlier figure that was weighed down by one-time charges.

TOPICS:

Bristol-Myers 3Q Profit Rises 2%

October 27, 2011 7:27 am | by Linda A. Johnson | News | Comments

Drugmaker Bristol-Myers Squibb Co. reported a 2% increase in its third-quarter profit, as price increases and higher sales of several key medicines were mostly offset by higher taxes and increased research and marketing costs.

TOPICS:

MRI Software System

October 26, 2011 12:44 pm | Product Releases | Comments

Aspect Imaging’s Certainti software offers a push button approach for preclinical research applications on its M2 MRI system.

Phase 1 Trial Completion of AP301

October 26, 2011 12:38 pm | News | Comments

Apeptico announced completion of a Phase 1 clinical trial for its pulmonary sodium ion channel activator AP301.

TOPICS:

Inhibitor Reduces Lung Function Loss

October 26, 2011 12:34 pm | News | Comments

Boehringer Ingelheim’s investigational tyrosine kinase inhibitor BIBF 1120 demonstrated a positive trend in reducing lung function decline in patients with idiopathic pulmonary fibrosis.

TOPICS:

FDA Flexible in Reviewing Rare Disease Therapies

October 26, 2011 12:31 pm | News | Comments

The National Organization for Rare Disorders released a report documenting flexibility in the Food and Drug Administration review of potential treatments for patients with rare diseases.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading